Jiangsu Nhwa Pharmaceutical Co Ltd (SZSE:002262) Share Price

Company Profile

Business description
Jiangsu Nhwa Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in the manufacturing of APIs and dosages. The company markets its pharmaceutical products in four main categories: anesthetic drugs, such as midazolam injection and etomidate fat emulsion injection; psychiatric drugs, including risperidone tablets and related products; neurological drugs, such as gabapentin capsules; and bulk pharmaceuticals, including fenofibrate and miconazole nitrate. In addition, the company is also involved in the pharmaceuticals trading business.
Contact
No. 31, Longhu West Road
Enhua Technology Building
Economic and Technological Development Zone
Xuzhou221009
CHN
T: +86 51687767115
https://www.nhwa-group.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
6,003

Recommended

Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.

Ananya Chag | 27 April 2026

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.

Malik Ahmed Khan, CFA | 24 April 2026

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Mark Taylor | 24 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,935.00	14.40	-0.16%
CAC 40	8,112.92	29.00	-0.36%
DAX 40	24,033.15	50.38	-0.21%
Dow JONES (US)	49,149.78	18.01	-0.04%
FTSE 100	10,310.41	10.68	-0.10%
HKSE	25,679.78	245.87	-0.95%
NASDAQ	24,700.74	186.36	-0.75%
Nikkei 225	59,917.46	619.90	-1.02%
NZX 50 Index	12,764.40	110.54	-0.86%
S&P 500	7,139.99	33.92	-0.47%
S&P/ASX 200	8,710.70	10.50	-0.12%
SSE Composite Index	4,078.64	7.71	-0.19%